{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion requires the response to suggest that a small number of executives (e.g., 2-5 FTEs) are sufficient substance for a major pharma group's global IP principal. The candidate answer explicitly states that the recommendation requires senior decision-makers to move or a material portion of C-suite/VP level who control risks and IP decisions to be Ireland-based, and that the structure must be substance-led, not paper-led. It does not suggest that 2-5 FTEs are sufficient; rather, it emphasizes that the *key* value-creating functions and risk control must move to Ireland to support the >50% profit shift, which implies a significant substance requirement, not a minimal one.\", \"criterion_id\": \"77a6a9a4-85a5-4ef3-a58c-6a3623970e43\"}", "usage": {"prompt_tokens": 1527, "completion_tokens": 201, "total_tokens": 1728}, "latency_s": 0.8145195420365781, "request_id": "xByVafeDLa2xnsEPvd25uQM", "raw_response": null}